Related Experiment Video
Updated: Jan 31, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic
Shengwei Wang1, Hao Cui2, Changpeng Song3
1Department of Cardiovascular Surgery, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
Obstructive sleep apnea (OSA) is common in hypertrophic obstructive cardiomyopathy (HOCM) and linked to nonsustained ventricular tachycardia (NSVT). OSA severity correlates with NSVT risk, a marker for sudden cardiac death.
Area of Science:
- Cardiology
- Sleep Medicine
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) increases risk of arrhythmias and sudden cardiac death.
- Obstructive sleep apnea (OSA) is prevalent in HCM patients and linked to atrial fibrillation.
Purpose of the Study:
- To investigate the association between nonsustained ventricular tachycardia (NSVT) and OSA in patients with hypertrophic obstructive cardiomyopathy (HOCM).
Main Methods:
- 130 HOCM patients underwent polysomnography and Holter ECG.
- Data analyzed for correlation between OSA severity and NSVT prevalence.
Main Results:
- 55% of patients had OSA; 21% had NSVT.
- NSVT prevalence increased significantly with OSA severity (P < .001).
- Apnea-hypopnea index and family history of HCM/SCD were independent predictors of NSVT.
Conclusions:
- OSA presence and severity are independently associated with NSVT in HOCM patients.
- NSVT is a significant risk factor for adverse cardiovascular events in this population.
Background:
Hypertrophic cardiomyopathy (HCM) is associated with arrhythmias and cardiovascular death. Obstructive sleep apnea (OSA) is highly prevalent and independently associated with atrial fibrillation in patients with HCM.
Objective:
The purpose of this study was to determine the relationship between nonsustained ventricular tachycardia (NSVT) and OSA in hypertrophic obstructive cardiomyopathy (HOCM).
Methods:
One hundred thirty consecutive patients with a confirmed diagnosis of HOCM in Fuwai Hospital between September 2017 and May 2018 were included. Polysomnography and Holter electrocardiography were performed in all patients.
Results:
Of 130 patients, 72 (55%) were diagnosed with OSA, including 38 with mild, 21 with moderate, and 13 with severe OSA, and 27 patients (21%) had NSVT. The prevalence of NSVT increased with the severity of OSA (none, mild, moderate, and severe: 12%, 16%, 33%, and 54%, respectively; P < .001 for trend). Compared to patients without NSVT, the apnea-hypopnea index was significantly higher in patients with NSVT among the different OSA groups (mild, moderate, and severe: 12 [11-13] vs 7 [6-8], P = .001; 24 [22-28] vs 19 [17-22], P = .01; and 54 [41-62] vs 34 [31-39], P = .008). In multivariate logistic regression analysis, family history of HCM or sudden cardiac death (odds ratio 6; 95% confidence interval 2-22; P = .005) and apnea-hypopnea index (odds ratio 1.07; 95% confidence interval 1.02-1.12; P = .001) were the only factors associated with NSVT after adjustment for age, sex, and body mass index.
Conclusion:
The presence and severity of OSA in patients with HOCM is independently associated with NSVT, which is a risk factor for sudden cardiac death and cardiovascular death in this population.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Sleep Apnea
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Design Example: Measuring Distance Between Two Points with Obstructions
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction

